As such we were unable to examine the influence of asthma severity or examine sub-groups characterized by amyloid and tau positivity to ascertain impact on those further along the Alzheimer’s disease continuum.6 As this was a retrospective study, we were dependent on prescription medication to determine asthma status. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.